Francis Richard D

President and CEO

Francis Richard D has filed 5 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.

On the most recent filing, Francis Richard D is listed as President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Francis Richard D reported no open-market purchases and 5 open-market sales totaling $31.3M in TEVA. The largest disclosed transaction in the window is a sale of 447,778 TEVA shares on Feb 15, 2026, worth $15.3M.

Companies traded

Other insiders at TEVA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$31.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TEVASale$211KJun 8SEC ↗
TEVASale$634KMar 9SEC ↗
TEVASale$759KMar 6SEC ↗
TEVASale$14.3MMar 5SEC ↗
TEVASale$15.3MFeb 18SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Francis Richard D made?

Francis Richard D has filed 5 SEC Form 4 filings (14 transaction rows) across 1 company since 2026.

Which companies does Francis Richard D trade?

Francis Richard D has filed SEC Form 4 disclosures for 1 company, including TEVA.

When was Francis Richard D's most recent SEC Form 4 filing?

Francis Richard D's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.

What is Francis Richard D's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Francis Richard D is listed as President and CEO.

What is Francis Richard D's total buy and sell value in the current window?

Inside the rolling retention window, Francis Richard D bought $0 and sold $31.3M based on SEC Form 4 filings.

What was Francis Richard D's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 447,778 TEVA shares on 2026-02-15, worth $15.3M, per SEC Form 4 filings.